-
1
-
-
0001449665
-
A new product growth for model consumer durables
-
Bass, F. M. 1969. A new product growth for model consumer durables. Management Sci. 15 215-227.
-
(1969)
Management Sci
, vol.15
, pp. 215-227
-
-
Bass, F.M.1
-
4
-
-
38849085391
-
-
Working paper, London Business School, London, UK
-
Crama, P., B. De Reyck, Z. Degraeve. 2006. Milestone payments or royalties? Contract design for R&D licensing. Working paper, London Business School, London, UK.
-
(2006)
Milestone payments or royalties? Contract design for R&D licensing
-
-
Crama, P.1
De Reyck, B.2
Degraeve, Z.3
-
5
-
-
34548446273
-
Project options valuation with net present value and decision tree analysis
-
Forthcoming
-
De Reyck, B., Z. Degraeve, R. Vandenborre. 2008. Project options valuation with net present value and decision tree analysis. Eur. J. Oper. Res. Forthcoming.
-
(2008)
Eur. J. Oper. Res
-
-
De Reyck, B.1
Degraeve, Z.2
Vandenborre, R.3
-
6
-
-
0035336557
-
New drug development in U.S. 1963-1999
-
DiMasi, J. A. 2001. New drug development in U.S. 1963-1999. Clinical Pharmacology Therapeutics 69 286-296.
-
(2001)
Clinical Pharmacology Therapeutics
, vol.69
, pp. 286-296
-
-
DiMasi, J.A.1
-
7
-
-
0037374498
-
The price of innovation: New estimates of drug development costs
-
DiMasi, J. A., R. W. Hansen, H. G. Grabowski. 2003. The price of innovation: New estimates of drug development costs. J. Health Econom. 22 151-186.
-
(2003)
J. Health Econom
, vol.22
, pp. 151-186
-
-
DiMasi, J.A.1
Hansen, R.W.2
Grabowski, H.G.3
-
8
-
-
38849085393
-
-
Study shows pharmaceutical licensing deals stem from existing relationships. Retrieved December 26
-
Drug Week. 2003. Study shows pharmaceutical licensing deals stem from existing relationships. Retrieved December 26, 2003 http://www.newsrx.com/ newsletters/Drug-Week/2003-12-26/122620033333437W.html.
-
(2003)
Drug Week. 2003
-
-
-
9
-
-
0028558896
-
Returns to R&D on new drug introductions in the 1980s
-
Grabowski, H. G., J. M. Vernon. 1994. Returns to R&D on new drug introductions in the 1980s. J. Health Econom. 13 383-406.
-
(1994)
J. Health Econom
, vol.13
, pp. 383-406
-
-
Grabowski, H.G.1
Vernon, J.M.2
-
10
-
-
0011804726
-
Economic analysis of R&D projects: An options approach
-
Herath, H. S. B., C. S. Park. 1999. Economic analysis of R&D projects: An options approach. Engrg. Economist 44 1-35.
-
(1999)
Engrg. Economist
, vol.44
, pp. 1-35
-
-
Herath, H.S.B.1
Park, C.S.2
-
11
-
-
15044340111
-
Valuation for the strategic management of research and development projects: The deferral option
-
Lewis, N., D. Enke, D. Spurlock. 2004. Valuation for the strategic management of research and development projects: The deferral option. Engrg. Management J. 16 36-48.
-
(2004)
Engrg. Management J
, vol.16
, pp. 36-48
-
-
Lewis, N.1
Enke, D.2
Spurlock, D.3
-
12
-
-
0001148463
-
Bayesian estimation and control of detailing effort in a repeat purchase diffusion environment
-
Lilien, G. L., A. G. Rao, S. Kalish. 1981. Bayesian estimation and control of detailing effort in a repeat purchase diffusion environment. Management Sci. 27 493-507.
-
(1981)
Management Sci
, vol.27
, pp. 493-507
-
-
Lilien, G.L.1
Rao, A.G.2
Kalish, S.3
-
13
-
-
0003114587
-
The valuation of risk assets and the selection of risky investments in stock portfolios and capital budgets
-
Lintner, J. 1965. The valuation of risk assets and the selection of risky investments in stock portfolios and capital budgets. Rev. Econom. Statist. 47 13-37.
-
(1965)
Rev. Econom. Statist
, vol.47
, pp. 13-37
-
-
Lintner, J.1
-
14
-
-
4544278933
-
-
MarketData Enterprises, Inc, 7th ed, The retail meal replacements and appetite suppressants market. Market report October
-
MarketData Enterprises, Inc. 2002. The US weight loss and diet control market, 7th ed.: The retail meal replacements and appetite suppressants market. Market report (October).
-
(2002)
The US weight loss and diet control market
-
-
-
16
-
-
38849191285
-
-
Ruback, R. S, D. Krieger. 2000. Merck & Co, Evaluating a Drug Licensing Opportunity. Case 9-201-023, Harvard Business School Publishing, Boston, MA
-
Ruback, R. S., D. Krieger. 2000. Merck & Co.: Evaluating a Drug Licensing Opportunity. Case 9-201-023, Harvard Business School Publishing, Boston, MA.
-
-
-
-
17
-
-
84980092818
-
Capital asset prices: A theory of market equilibrium under conditions of risk
-
Sharpe, W. F. 1965. Capital asset prices: A theory of market equilibrium under conditions of risk. J. Finance 19 425-442.
-
(1965)
J. Finance
, vol.19
, pp. 425-442
-
-
Sharpe, W.F.1
|